ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

24 hedge funds and large institutions have $1.77M invested in Albireo Pharma, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 6 closing their positions.

Holders
24
Holders Change
-5
Holders Change %
-17.24%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
6
Closed
6
Calls
$24K
Puts
–
Net Calls
+$24K
Net Calls Change
-$4K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$1.11M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$475K
3
Citadel Advisors
3
Citadel Advisors
Florida
$23K
4
VKH
4
Virtu KCG Holdings
New York
$21K
5
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$12K

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$0
2
SM
2
Sabby Management
Florida
$0
3
BFA
3
BlackRock Fund Advisors
California
$3K
4
SKK
4
Shepherd Kaplan Krochuk
Massachusetts
$0
5
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$3K
Name Market Value Shares Shares
Change 		Shares
Change %
LTFS
26
Ladenburg Thalmann Financial Services
Florida
$0 1,000 – –
AIM
27
Advantage Investment Management
Iowa
$0 250 – –
Creative Planning
28
Creative Planning
Kansas
$0 150 – –
PMFA
29
Plante Moran Financial Advisors
Michigan
$0 1,470 – –
Bank of America
30
Bank of America
North Carolina
$0 746 +4 +0.5%
1
2